Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-28T07:30:03.388Z Has data issue: false hasContentIssue false
  • English
  • Français

On the possible schistosomulicidal effect of macrophage-derived lysozyme

Published online by Cambridge University Press:  06 April 2009

E. Flescher ,
Y. Keisari ,
J. Lengy  and
D. Gold
E. Flescher
Affiliation:
Division of Clinical Immunology, Department of Medicine, The University of Texas Health Science Center of San Antonio, San Antonio, Texas 78284, USA
Y. Keisari
Affiliation:
Department of Human Microbiology, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel
J. Lengy
Affiliation:
Department of Human Microbiology, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel
D. Gold
Affiliation:
Department of Human Microbiology, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel
Get access Rights & Permissions [Opens in a new window]

Extract

Lysozyme secretion from macrophages of Schistosoma mansoni-infected mice was time dependent, rising significantly from the 8th week post-infection, the macrophages thereafter exhibiting very high levels (> 90%) of schistosomulicidal activity. Despite the ability of lysozyme to kill schistosomula in vitro, the concentrations required for such killing were several hundred-fold to several thousand-fold higher than those detected in the supernatants from infected-mice macrophages cultured with or without schistosomula. An in vitro lysozyme inhibitor, N, N, N-triacetyl chitobiose, did not abrogate the cytotoxic ability of macrophages from schistosome-infected mice, but an inhibitor of arginine-dependent cytotoxicity, NG-monomethyl arginine, markedly inhibited schistosomulicidal activity. Evidently, concentrations of ambient lysozyme from macrophage cultures are too low to affect schistosomula in culture, while the main schisto-somulicidal pathway in vitro seems to be arginine dependent.

Keywords

Schistosoma mansonischistosomulalysozymemacrophagesarginine
Type
Research Article
Information
Parasitology , Volume 103 , Issue 1 , August 1991 , pp. 61 - 64
Copyright
Copyright © Cambridge University Press 1991

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cheng, T. C. & Dougherty, W. J. (1989). Ultrastructural evidence for the destruction of Schistosoma mansoni sporocysts associated with elevated lysosomal enzyme levels in Biomphalaria glabrata. Journal of Parasitology 75, 928–41.CrossRefGoogle ScholarPubMed
Chipman, D. M. & Sharon, N. (1969). Mechanism of lysozyme action. Science 165, 454–65.CrossRefGoogle ScholarPubMed
Diluzio, N. R. (1979). Lysozyme, glucan-activated macrophages and neoplasia. Journal of the Reticuloendothelial Society 26, 67–81.Google Scholar
Gordon, S., Todd, J. & Cohn, Z. A. (1974). In vitro synthesis and secretion of lysozyme by mononuclear phagocytes. Journal of Experimental Medicine 139, 1228–48.CrossRefGoogle ScholarPubMed
Hibbs, J. R. Jr, Taintor, R. & Vavrin, Z. (1987). Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrate. Science 235, 473–6.CrossRefGoogle Scholar
HsÜ, S. Y., Li, Y., HsÜ, H. F., Isacson, P. & Cheng, H. F. (1977). Schistosoma mansoni and S. japonicum: methylene blue test for the viability of schistosomula in vitro. Experimental Parasitology 41, 329–34.CrossRefGoogle ScholarPubMed
James, S. L. & Glaven, J. (1989). Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. Journal of Immunology 143, 4208–12.CrossRefGoogle ScholarPubMed
James, S. L., Sher, A., Lazdins, J. K. & Meltzer, M. S. (1982). Macrophages as effector cells of protective immunity in murine schistosomiasis. II. Killing of newly transformed schistosomula in vitro by macrophages activated as a consequence of Schistosoma mansoni infection. Journal of Immunology 128, 1535–40.CrossRefGoogle ScholarPubMed
Lazdins, J. K., Stein, M. J., David, J. R. & Sher, A. (1982). Schistosoma mansoni: rapid isolation and purification of schistosomula of different developmental stages by centrifugation on discontinuous density gradients of percoll. Experimental Parasitology 53, 39–44.CrossRefGoogle ScholarPubMed
McLaren, D. J. & James, S. L. (1985). Ultrastructural studies of the killing of schistosomula of Schistosoma mansoni by activated macrophages in vitro. Parasite Immunology 7, 315–31.CrossRefGoogle ScholarPubMed
McLaren, D. J., Peterson, C. G. B. & Venge, P. (1984). Schistosoma mansoni: further studies of the interaction between schistosomula and granulocyte-derived cationic proteins in vitro. Parasitology 88, 491–503.CrossRefGoogle ScholarPubMed
Malkin, R., Flescher, E., Lengy, J. & Keisari, Y. (1986). The interaction between macrophages and developmental stages of Schistosoma mansoni: effect of macrophage function modulators on the viability of S. mansoni in vivo and in vitro. Journal of Biological Response Modifiers 5, 470–80.Google ScholarPubMed
Malkin, R., Flescher, E., Lengy, J. & Keisari, Y. (1987). On the interaction between macrophages and developmental stages of Schistosoma mansoni: the cytotoxic mechanisms involved in macrophage-mediated killing of schistosomula in vitro. Immunobiology 176, 63–72.CrossRefGoogle ScholarPubMed
Perrotto, J. L., Falchuk, K. R., Pelly, R. P. & Warren, K. S. (1976). Serum lysozyme and β-glucuronidase in experimentally induced granulomatous inflammation. Annals of the New York Academy of Sciences 278, 592–8.CrossRefGoogle ScholarPubMed